{"DataElement":{"publicId":"3233425","version":"1","preferredName":"Bioassay Neoplasm Heterogeneous Assessment Description Text","preferredDefinition":"The free text field used to describe how a benign or malignant tissue growth resulting from uncontrolled cell proliferation heterogeneity will be handled.","longName":"BIOA_NEOP_HTR_D_TXT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3233424","version":"1","preferredName":"Bioassay Neoplasm Heterogeneous Assessment","preferredDefinition":"A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. (from MSH98)_A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The quality or state of consisting of elements that are not of the same kind or nature._The final result of a determination of the value, significance, or extent of.","longName":"BIOA_NEOP_HETER_ASES","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2176953","version":"1","preferredName":"Assay","preferredDefinition":"A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. (from MSH98)","longName":"Assay","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Bioassay","conceptCode":"C16341","definition":"A laboratory test or analysis of the biological activity of a substance performed by studying its effect on an organism or in a test tube under controlled conditions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A19-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3233422","version":"1","preferredName":"Neoplasm Heterogeneous Assessment","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The quality or state of consisting of elements that are not of the same kind or nature.:The final result of a determination of the value, significance, or extent of.","longName":"C3262:C28359:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Heterogeneity","conceptCode":"C28359","definition":"The quality or state of consisting of elements that are not of the same kind or nature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2760A1E-91B3-C7DE-E040-BB89AD436E73","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-04","modifiedBy":"ONEDATA","dateModified":"2011-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2760A1E-91C4-C7DE-E040-BB89AD436E73","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2954078","version":"1","preferredName":"Assessment Description Text","preferredDefinition":"The final result of a determination of the value, significance, or extent of._A written or verbal account, representation, statement, or explanation of something._The words of something written.","longName":"ASSE_DESC_TEXT","context":"PhenX","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2954077","version":"1","preferredName":"Assessment Description Text","preferredDefinition":"The final result of a determination of the value, significance, or extent of.:Description; a statement that represents something in words.:Text; the words of something written.","longName":"C0679207:C25365:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C0679207","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"2"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"75FD9E5B-7765-D5F0-E040-BB89AD4334FD","latestVersionIndicator":"Yes","beginDate":"2009-10-15","endDate":null,"createdBy":"PANH","dateCreated":"2009-10-15","modifiedBy":"ONEDATA","dateModified":"2009-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"75FD9E5B-7776-D5F0-E040-BB89AD4334FD","latestVersionIndicator":"Yes","beginDate":"2009-10-15","endDate":null,"createdBy":"PANH","dateCreated":"2009-10-15","modifiedBy":"SBR","dateModified":"2015-12-21","changeDescription":" Changed from caBIG to PhenX for PANH by script 2015-12-21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3232302","version":"1","longName":"In Situ Hybridization Biomarker Template","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"How will tumor heterogeneity","type":"Preferred Question Text","description":"How will tumor heterogeneity be handled?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A2760A1E-91DE-C7DE-E040-BB89AD436E73","latestVersionIndicator":"Yes","beginDate":"2011-05-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-04","modifiedBy":"MAESKEB","dateModified":"2011-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}